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Purpose: The evaluation of coronary artery disease (CAD) in patients undergoing vascular 
surgery can provide information with respect o perioperative and long-term risk for 
CAD-related events. However, the extent o which the required surgical procedure itself 
imparts additional risk beyond that dictated by the presence of CAD determinants remains 
in question. The purpose of this study was to quantify the relative contributions ofspecific 
vascular procedures and CAD markers on perioperative and long-term cardiac risk. 
Methods: The study cohort comprised 547 patients undergoing vascular surgery from two 
medical centers who underwent clinical evaluation, dipyridamole thallium testing, and 
either aortic (n --- 321), infrainguinal (n = 177), or carotid (n = 49) vascular surgery 
between 1984 and 1991. Perioperative and late cardiac risk of fatal or nonfatal myocardial 
infarction (MI) was compared for the three procedures before and after adjustment for the 
influence ofcomorbid factors. These adjusted estimates may be regarded as the component 
of risk because of type of surgery. 
Results: Perioperative MI occurred in 6% of patients undergoing aortic and carotid artery 
surgery, and in 13% of patients undergoing infrainguinal procedures (p = 0.019). 
Significant (p < 0.05) predictors of MI were history of angina, fixed and reversible 
dipyridamole thallium defects, and ischemic ST depression during testing. Although 
patients undergoing infrainguinal procedures exhibited more than twice the risk for 
perioperative MI compared with patients undergoing aortic surgery (relative risk: 2.411.2 
to 4.5, p = 0.008]), this value was reduced to insignificant levels (1.610.8 to 3.2, 
p = 0.189]) after adjustment for comorbid factors. There was tittle change in comparative 
risk between carotid artery and aortic procedures before (1.010.3 to 3.6, p = 0.95]) or 
after (0.6[0.2 to 2.3, p = 0.4]) covariate adjustment. The 4-year cumulative vent-free 
survival rate was 90% -+ 2% for aortic, 74% + 5% for infrainguinal, and 78% + 7% for 
carotid artery procedures (p = 0.0001). Predictors of late MI included history of angina, 
congestive heart failure, diabetes, fixed dipyridamole thallium defects, and perioperative 
MI. Patients undergoing infrainguinal procedures exhibited a threefold greater isk for 
late events compared with patients undergoing aortic procedures (relative risk: 3.011.8 to 
5.1,p = 0.005]), but this value was reduced to 1.3(0.8 to 2.3,p = 0.32) after adjustment. 
Long-term risk among patients undergoing carotid artery surgery was less dramatically 
altered by risk factor adjustment. 
Conclusion: In current practice, among patients referred for dipyridamole t sting before 
operation, observed ifferences in cardiac risk of vascular surgery procedures may be 
primarily attributable to readily identifiable CAD risk factors rather than to the specific 
type of vascular surgery. Thus the cardiac and diabetic status of patients hould be given 
careful consideration whenever possible, regardless of surgical procedure to be performed. 
(J VASC SURG 1995;21:935-44.) 
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Table I. Distribution of clinical and DTHAL variables according to the type of surgical procedure 
Procedure 
Aortic Infrainguinal Carotid Overall Aortic vs infrainguinal Carotid vs infrainguinal 
(n = 321) (n = 177) (n = 49) p value p value p value 
Variable 
Mean age 66 _+ 10 68 + 9 65 + 8 0.787 
Advanced age (>70 yrs.) 110 (34%) 69 (39%) 15 (31%) 0.436 
Male 222 (69%) 116 (66%) 30 (61%) 0.455 
History of MI 11I (35%) 88 (50%) 15 (31%) 0.002 0.0009 
History of angina 67 (21%) 55 (31%) 19 (39%) 0.004 0.011 
History of CHF 19 (6%) 32 (18%) 3 (6%) 0.0001 0.00002 
Diabetes mellitus 34 (11%) 67 (38%) 13 (27%) 0.0001 0.00001 
Prior CABG 39 (12%) 24 (14%) 3 (6%) 0.367 
Dipyridamole thallium results 
Fixed defects 135 (42%) 99 (56%) 20 (41%) 0.009 0.003 
Reversible defects 129 (40%) 95 (54%) 24 (49%) 0.013 0.003 
Ischemic ST dep 27 (9%) 2I (12%) 8 (16%) 0.168 
0.017 
0.309 
0.04 
0.14 
0.06 
0.56 
CHF, Congestive heart failure; ST dep, ST depression. 
Table II, A. Stepwise logistic regression results-predictors of perioperative outcomes ~ 
Variable RR 95% Confidence interval p Value 
History of angina 2.1 1.1-4.0 0.034 
Fixed defects 2.1 1.1-4.3 0.030 
Reversible defects 3.7 1.7-8.3 0.001 
Ischemic ST dep 3.0 1.4-6.5 0.005 
Prior CABG 0.1 0.2-0.9 0.035 
ST dep, ST depression. 
3*Fatal or nonfatal MI. 
A significant proportion of patients with periph- 
eral vascular disease will harbor either occult or 
clinically evident coronary artery disease (CAD), 1 
and it is common knowledge that such associated 
CAD is the principal source of perioperative and late 
cardiac morbidity and death. The logical posture that 
perioperative risk is related to both the extent of CAD 
and the magnitude of the surgical procedure is 
reflected in the literature mphasizing cardiac risk in 
aortic surgery. 2-s Recently, however, cardiac ompli- 
cations are being reported with equal or greater 
frequency among patients undergoing infrainguinal 
or carotid artery surgery. Krupski et al. 6 demon- 
strated that cardiac morbidity rates at 2 years were 
greater for infrainguinal versus abdominal aortic 
procedures among 140 male patients. The observed 
differences were attributed to diabetic and other 
coronary risk factors. Burnham et al.7 ascribed 
differences in cardiac morbidity rates between aortic 
and femoropopliteal procedures to advanced age 
among the latter group. In a related earlier study, 
Cutler et al. 8 also reported increased morbidity rates 
for infrainguinal versus aortic procedures. The au- 
thors speculated that the differences were due to 
more intensive screening of patients undergoing 
aortobifemoral procedures, diabetic risk factors, and 
the observation by KaUero et al.9 of the association 
between lower extremity and three-vessel CAD. 
Although these studies reported ifferences in 
complication rates among surgical procedures, the 
distinction between procedure-specific risk and that 
attributable to the spectrum of CAD risk factors 
remains ill defined. The purpose of this study was to 
quantify the perioperative and late risk of myocardial 
infarction (MI) for major vascular procedures and to 
determine the relative contributions of the Specific 
procedure and clinical and dipyrimadole thallium 
variables to short- and long-term cardiac risk. 
METHODS 
The study group was selected from a cohort of 
606 consecutive patients receiving dipyridamole 
thallium before vascular surgery at two university 
hospitals (Massachusetts General Hospital, Boston, 
and University of Massachusetts Medical Center, 
Worcester) between August 1984 and December 
1991. In 39 patients, vascular surgery was cancelled 
because of severe CAD. An additional 20 patients 
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Table II, B. Stepwise Cox regression results-predictors of long-term outcomes ~ 
Variable RR 95% Confidence interval p Value 
Diabetes mellitus 1.8 1.1-3.1 0.030 
History of angina 1.7 1.0-2.9 0.049 
History of CHF 3.6 2.0-6.4 0.0001 
Fixed defects 2.6 1.5 -4.4 0.001 
Prior CABG 0.5 0.2-1.0 0.049 
Perioperative nonfatal MI 5.5 3.1-9,8 0.0001 
CHF, Congestive heart failure. 
~Fatal or nonfatal MI. 
Table III, A. Perioperative outcomes according to surgical procedure 
Procedure 
Aortic (n = 321) Infrainguinal (n = 177) Carotid (n = 49) 
Overall Ao vs Inf Car vs Inf 
Variable No. % No. % No. % p value p value p value 
Fatal/nonfatal MI 19 6 23 13 3 6 0.019 0.006 0.18 
All cause of death 16 5 6 3 0 0 0.222 
Nonfatal MI 9 3 18 10 3 6 0.003 0.0005 0.38 
Ao, Aortic; Inf, infrainguinal; Car, carotid artery. 
who underwent miscellaneous vascular procedures 
were also excluded. The remaining 547 patients who 
underwent prompt abdominal aortic (n = 321), 
infrainguinal (n = 177), and carotid artery (n = 49) 
reconstructive procedures comprised the study 
group. The proportion of all patients undergoing 
vascular surgery referred for dipyridamole thallium 
testing was approximately 30% for both aortic and 
infrainguinal (femoropopliteal, femorotibial) proce- 
dures, and 10% for carotid artery surgery at both 
medical centers. 
Clinical and historical patient information was 
obtained retrospectively through careful medical 
record review by investigators who were not involved 
in the patients' clinical care. These variables included 
the presence of the following: advanced age (> 70 
years), a history of angina, a history of myocardial 
infarction or Q wave on electrocardiography, a 
history of diabetes mellitus, and a history of conges- 
tive heart failure and coronary revascularization 
before the current hospitalization. 
The administration f intravenous dipyridamole 
and thallium was supervised by a cardiologist who 
recorded changes in pulse, blood pressure, and 
electrocardiography results. Ischemic electrocardio- 
graphic hanges were defined as 1 mm or greater of 
horizontal or downsloping ST segment depression 
compared with baseline tracings. Planar thallium 
imaging was used. Initial images were obtained in 
three standard views (anterior, left anterior oblique, 
and lateral) immediately after the administration f
dipyridarnole and thallium, and delayed images were 
obtained 3 hours later. Positive results were de- 
scribed as planar myocardial scintigraphic images 
that, on review by two experienced observers, 
showed fixed defects or images howing defects that 
partially or completely redistributed on delayed 
(3-hour) imaging. The thallium scans were quali- 
tatively interpreted by an experienced nuclear car- 
diologist who was unaware of the patients' clinical 
course. Thallium reinjection or quantitation of the 
degree of redistribution was not performed. Di- 
pyridamole thallium results were made available to 
all treating physicians. 
Outcomes were assessed by careful medical record 
review or interview of the treating physicians, the 
patients, and their families by cardiology research 
fellows who were not involved in the patients' clinical 
care. Outcomes were defined as nonfatal MI or 
heart-related death. For the definition of nonfatal MI, 
the University of Minnesota criteria were used: a new 
Q wave on electrocardiography of I mm or greater, 
creatine-kinase-MB of 5% or greater, or both. Fatal 
events were defined as sudden death directly attrib- 
utable to MI or congestive heart failure. All reported 
fatal events were confirmed by review of hospital 
records, autopsy findings, and death certificates. All 
reported nonfatal events were confirmed by medical 
record review of the electrocardiograms or enzyme 
criteria cited previously. No patients were lost to 
follow-up or could not have study events confirmed. 
Perioperative events were defined as those occurring 
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Fig. 1. Cumulative event (fatal/nonfatal MI) free survival rates according totype f sur ical 
procedure. 
Table III, B. No CAD risk factors (n -- 148) 
Aortic Infrainguinal Carotid Overall 
(n = 98) (n = 38) (n = 12) p value 
Fatal/nonfatalMI 1 (1%) 0 (0%) 0 (0%) 0.700 
All cause of death 2 (2%) 0 (0%) 0 (0%) 0.596 
NonfatalMI 0 (0%) 0 (0%) 0 (0%) 1.00 
0 to 30 days after vascular surgery. Long-term events 
were defined as those occurring 31 days or more after 
surgery. 
Statistical analysis A popular statistical package 
(BMDP Statistical Software, Los Angeles, Calif.) was 
used for univariate (BMDP4f), logistic (BMDPLR), 
survival (BMDP11), and Cox (BMDP21) analyses. 
The distribution of clinical, historical, and dipyri- 
damole thallium factors was first compared among 
the three procedures by use of chi-square and Fisher 
exact ests where appropriate. Univariate predictors 
of perioperative and long-term adverse vents were 
similarly determined. Variables associated with poor 
outcomes or unequally distributed between surgical 
treatment groups at thep value < 0.10 were chosen 
for inclusion into the multivariate models. 
For the multivariate analyses, stepwise logistic 
and Cox regressions were first performed to identify 
significant (p < 0.05), independent predictors of 
perioperative and late outcomes, respectively. Sec- 
ond, nonstepwise r gression analyses were conducted 
with use of these predictors plus variables comparing 
the type of surgery (i.e., "infrainguinal vsaortic" and 
"carotid versus aortic"). To derive these variables, it 
is necessary that one of the surgical categories be 
arbitrarily designated as a reference group (e.g., 
aortic surgery). This method permits the estimation 
of a "surgical relative risk" adjusted for the influence 
of the nonsurgical factors. 1° The magnitude of this 
adjusted risk is indicative of the contribution of 
surgical factors to the adverse outcome. Finally, these 
adjusted relative risks were compared with the crude 
or unadjusted relative risks computed from the 
simple ratio of event rates for the particular surgical 
category and the designated reference group (aortic 
surgery). 
To further examine the impact of CAD risk 
factors on morbidity, patients were stratified accord- 
ing to the presence or absence of predictors identified 
by the regression models. Perioperative event rates 
and cumulative event-free survival rates were then 
calculated and compared by use of chi-square and 
Mantel-Cox tests, respectively. Non-heart-related 
deaths were treated as censored observations for the 
survival analyses. However, separate analyses were 
performed for all causes of death, heart-related death, 
and nonfatal MI. 
RESULTS 
The distribution of clinical, historical, and dipyr- 
idamole thallium variables according to operative 
procedure is illustrated in Table I. The prevalence of
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Table III, C. One or more CAD risk factors (n = 399) ~ 
Aortic Infrainguinal Carotid Overall Ao vs Inf Car vs Inf 
(n = 223) (n = 139) (n = 37) p value p value p value 
Fatal/nonfatalMI 18 (8%) 23 (17%) 3 (8%) 0.039 0.004 0.18 
All cause of death 14 (6%) 6 (4%) 0 (0.0%) 0.236 - - 
NonfatalMI 9 (4%) 18 (13%) 3 (8%) 0.008 0.0005 0.387 
Ao, Aortic; Inf, infrainguinal; Car, carotid artery. 
*History of angina, fixed and reversible dipyridamole thallium defects, ischemic ST depression during testing. 
Table IV, A. Crude and adjusted surgical RR for perioperative cardiac events ~according to the 
type of surgical procedure 
Variable Crude RR (95% CI) p Value Adjusted RR (95% CI) ~ p Value 
Infrainguinal (vs aortic) 2.4 (1.2-4.5) 0.008 1.6 (0.8-3.2) 0.189 
Carotid (vs aortic) 1.0 (0.3-3.6) 0.95 0.6 (0.2-2.3) 0.400 
~Fatal or nonfatal MI. 
tAdjusted for history of angina, fixed defects, reversible dipyridamole thallium defects, ischemic ST depression during dipyridamole 
thallium. 
cardiac risk factors, such as a history of MI, conges- 
tive heart failure, fixed and reversible dipyridamole 
thallium defects, and diabetes are all significantly 
greater among patients undergoing infrainguinal 
procedures compared with patients undergoing aor- 
tic procedures, and to a lesser extent, among patients 
undergoing carotid artery surgery, except for a 
history of angina. The other variables, namely, age, 
sex, prior coronary artery bypass grafting (CABG), 
and ischemic ST changes during dipyridamole thal- 
lium were venly distributed between groups. 
The results of the logistic regression analysis are 
detailed in Table II, A. The stepwise regression 
identified a history of angina, fixed and reversible 
dipyridamole thallium defects, and ischemic ST 
changes during dipyridamole thallium as indepen- 
dent predictors of perioperative fatal or nonfatal MI; 
prior CABG was protective. Cox regression (Table 
II, B) identified ahistory of angina, congestive heart 
failure, diabetes, fixed dipyridamole thallium defects, 
and nonfatal perioperative MI as predictors of 
long-term adverse vents, again with prior CABG 
demonstrating a protective ffect. 
Perioperative outcomes cla sed according to op- 
erative procedure are illustrated in Table III. There 
were a total of 45 cardiac events, 30 of which were 
nonfatal MI (67%). Both heart-related vent rates 
were significantly greater for infrainguinal (13%) 
compared with aortic (6%)(p = 0.006,p = 0.0001, 
respectively) procedures but not for infrainguinal 
compared with carotid artery procedures (6%) 
(p = 0.18,p = 0.38, respectively). Furthermore, all
cause of mortality rates did not differ according to 
procedure (p = 0.222). 
Among 148 patients lacking risk factors identified 
by logistic regression, there were no procedural 
differences (p = 0.7 to 1) and virtual freedom from 
adverse outcome; that is, there was only one event 
among this subset. Among the 399 patients exhib- 
iting one or more risk factors, all event rates were 
elevated with patients undergoing infrainguinal pro- 
cedures at significantly higher risk compared with 
patients undergoing aortic surgery, particularly for 
nonfatal cardiac events (p = 0.0005). There were a 
total of 44 events in this subset. The overall MI event 
rate among the 148 "low" risk patients ( < 1%) versus 
the 399 "high" risk patients (11%) was significantly 
different (p = 0.002). 
Fig. 1 illustrates the cumulative event 
(fatal/nonfatal MI) free survival according to proce- 
dure for patients undergoing 303 aortic, 171 infrain- 
guinal, and 48 carotid artery procedures. Median 
follow-up time for the entire cohort was 5 -+ 0.5 
years. In contrast to the perioperative events, 65% of 
late outcomes were due to fatal MI. By 24 months, 
procedural differences became apparent: he cumu- 
lative event-free survival rate at 2 years was 
95% ___ 2% for 210 patients undergoing aortic 
procedures, 88% + 2% for 101 patients undergoing 
infrainguinal procedures, and 86% +_ 5% for 25 
patients undergoing carotid artery surgery. Among 
patients undergoing infrainguinal surgery, there is 
a further decline in the survival rate at 3 years. By 
48 months, cumulative rates were 90% + 2%, 
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Fig. 2. A, Cumulative event-free survival rates for 147 patients exhibiting no preoperative 
CAD risk factors. B, Cumulative event-free survival rates among 375 patients exhibiting one or 
more preoperative risk factors (i.e., history of angina, history of diabetes, history ofCHF, fixed 
dipyridamole thallium defects). 
74% _+ 5% and 78% -+ 7% for 96 aortic, 35 infrain- 
guinal, and 11 carotid artery procedures, respectively. 
These differences persisted for the remainder of the 
follow-up period (Mantel-Cox p value of 0.0001). 
The influence of CAD risk factors on procedural 
differences in cumulative vent-free survival is illus- 
trated by the stratified results hown in Fig. 2. 
Among 147 patients exhibiting no CAD factors, 
there are no risk differences across procedures, and 
increased event free survival, up to 36 months; there 
were only five events in this subset. At 36 months, the 
rates are 98% _+ 1%, 90% + 7%, and 100% + 0% 
for aortic, infrainguinal, and carotid artery proce- 
dures, respectively (overall p value of 0.261). 
Among 375 patients exhibiting one or more 
CAD factors (Fig. 2, B) the procedural differences in 
event-free survival are again apparent, and rates are 
lower than the unstratified data shown previously, 
particularly for infrainguinal and carotid artery pro- 
cedures. At 48 months, the cumulative event-free 
survival rate is 85% -- 3% for aortic, 71% __ 5% for 
infrainguinal, and 70%--9% for carotid artery 
procedures (overall p value of 0.0007). There were 
64 events in this subset. 
Overall survival according to procedure is illus- 
trated in Fig. 3. More than half of the fatal events 
were heart related (60%). Differences between aortic 
and infrainguinal procedures do not become appar- 
ent until 36 months, whereas the survival pattern 
among patients undergoing carotid artery surgery is 
similar to that shown in Fig. 1. At 36 months, 
cumulative survival rates are 91% + 2%, 81% 
+ 4%, and 81% _+ 6% for patients undergoing 
aortic, infrainguinal, and carotid artery procedures, 
respectively (Overall p value 0.002). 
Table IV details the results of the quantitative 
JOURNAL OF VASCULAR SURGERY 
Volume 21, Number 6 L'Italien et al. 941 
_ 
I - -~"'----~0------- 0
. ~-A  ix S ' ' '~t  :1: T V 
._1 
> 
> 
n,, 
: : )  
ILl  
_> 
F-- 
._1 
60 
40 
20 
I 
0 6 
P=.002 
O--  0 AORTIC (N=303)  
• ~ • INFRAINGUINAL(N= 17,1 ) 
Z~ ~ Z~ CAROTID(N=48) 
I I I I I ! t I I 
12 18 24 30 36 42 48 54 60 
TIME (MONTHS) 
Fig. 3. Cumulative survival rates according to type of surgical procedure. 
assessment of procedure-specific risk. Adjusted sur- 
gical relative risks (RR) were obtained from the 
regression models hown in Table II, A and II, B and 
compared with the crude (univariate) estimates. 
These adjusted estimates may be regarded as that 
component of risk caused by the type of surgery 
required. Although patients undergoing infrain- 
guinal procedures exhibited more than twice the risk 
for perioperative events versus patients undergoing 
aortic surgery (crude RR 2.4,p = 0.008), this value 
was reduced to 1.6 (2 = 0.189) after adjustment for 
the CAD risk factors. There was little change in 
comparative risk between carotid and aortic proce- 
dures before (crude RR 1.0,p = 0.95) or after (RR 
0.6,p = 0.4) covariate adjustment. 
Patients undergoing infrainguinal surgery exhib- 
ited a threefold greater isk for long-term events 
compared with patients undergoing aortic surgery 
(crude RR 3.0,p = 0.005); however, this value was 
considerably reduced to 1.3 (2 = 0.32) after adjust- 
ment for comorbid factors. Long-term cardiac risk 
for patients undergoing carotid artery surgery was 
similarly elevated (crude RR 2.9, p = 0.0001) but 
was reduced somewhat after covariate adjustment 
(RR 2.1,p = 0.07). 
DISCUSSION 
This analysis corroborates and expands on our 
earlier finding 8of the significantly higher incidence of 
both perioperative and late adverse cardiac events 
among patients undergoing infrainguinal versus aor- 
tic procedures. Patients undergoing lower extremity 
procedures exhibited a twofold to threefold greater 
risk for fatal or nonfatal MI compared with patients 
undergoing aortic surgery. Long-term risk was also 
elevated among patients undergoing carotid surgery. 
Although previous authors have made similar 
observat ions,  69 this is the first large, diverse study to 
report quantitative relative risks for major vascular 
procedures, adjusted for the influence of clinical 
markers of CAD. 
Our results further indicate that these observed 
procedural risk differences are primarily attributable 
to a spectrum of CAD factors, which are more 
prevalent among patients undergoing infrainguinal 
and, to a lesser extent, carotid artery surgery com- 
pared with patients undergoing aortic procedures. 
Among 148 patients who exhibited no cardiac or 
diabetic risk factors, procedural risk differences were 
virtually eliminated, perioperative events were rare 
(0% to 1%), and cumulative vent-flee survival was 
considerably improved. Also, the independent effect 
of surgery, as indicated by the adjusted surgical RR, 
appears to be negligible for both perioperative and 
late MI incidence, particularly among patients un- 
dergoing infrainguinal procedures. Thus our results 
imply that surgery itself imparts minimal periopera- 
tive and long-term cardiac risk on average. Obviously, 
factors related to the surgery itself and unknown 
before operation will still play an important role in 
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Table IV, B. Crude and adjusted surgical RR for late cardiac events* according to the type of 
surgical procedure 
Variable Crude RR (95% CI) p Value Adjusted RR (95% CI) ~ p Value 
Infrainguinal (vs aortic) 2.9 (1.8-4.6) 0.0001 1.3 (0.8-2.3) 0.32 
Carotid (vs aortic) 3.0 (1.5-5.9) 0.005 2.1 (0.9-4.9) 0.07 
CHF, Congestive heart failure. 
*Fatal or nonfatal MI. 
?Adjusted for history of angina, history of diabetes, history of CHF, fixed dipyridamole thallium defects. 
determining individual risk. In an earlier report, 2we 
demonstrated that prolonged operative time was 
independently predictive of adverse events after 
aortic surgery despite a seemingly modest postoper- 
ative mortality rate of 2%. 
The results of other studies corroborate our 
finding that lower extremity procedures are associ- 
ated with a higher than expected morbidity rate, even 
when the indication for surgery is daudication. 
Krupsld et al. 6 reported perioperative and 2-year 
cardiac morbidity rates of 25% and 8% for 87 
infrainguinal versus 53 age-matched patients under- 
going aortic surgery, respectively. As seen in this 
study, the observed ifferences in morbidity rates 
between aortic and infrainguinal procedures were 
attributed primarily to concommittent cardiac or 
diabetic factors, and most perioperative and late 
deaths were heart related. Dawson et al.n reported a
S-year cumulative incidence of 34% among 129 
patients undergoing infrainguinal bypass, which is 
similar to this study. These authors also demon- 
strated that a spectrum of readily obtainable CAD 
markers was related tofatal cardiac events. Taylor and 
Porter ~2 demonstrated a correlation between the 
severity of lower extremity ischemia nd late death. 
The reported S-year survival rate for patients with 
claudication (67%) was similar to our infrainguinal 
group (62% _ 7%). Last, recent epidemiologic 
studies have shown that intermittent claudication 
doubles the risk of death in most populations) 31s 
One partial explanation for the observed proce- 
dural differences in morbidity rates may be selection 
bias. Preoperative dipyridamole thallium results were 
made available to physicians caring for all patients 
and tended to influence operative management. I  is 
thus possible that candidates for aortic surgery as a 
result of aortoiliac occlusive disease (AIOD) may 
have had surgery postponed or cancelled because of 
severe CAD as indicated by an abnormal scan result. 
If selection bias was operative, it is reasonable to 
expect fewer abnormal dipyridamole thallium scan 
results among patients with AIOD undergoing 
prompt vascular surgery. However, the percentage of
abnormal dipyridamole thallium results was similar 
for the 256 patients with abdominal aortic aneurysm 
and 67 patients with MOD in the current study 
(60% vs 65%, respectively, p = 0.450). 
Our aortic surgery results are similar to those 
reported elsewhere. For example, LaChappelle et 
el.16 reported an overall cardiac mortality rate of 3.4% 
among 146 patients undergoing elective abdominal 
aortic aneurysm repair. When patients were classed 
according to CAD risk status, the rates were 1.8% 
and 9.5% for low- and high-risk groups, respectively. 
Karla et al.17 found a perioperative cardiac morbidity 
rate of 6.3% among 555 patients who underwent 
elective abdominal aortic surgery, with an overall 
mortality rate of 2.2%. Last, Johnston and Skobie 3
reported an overall mortality rate of 4.8 % among 666 
patients undergoing surgery for nonruptured aortic 
aneurysm. Most of these deaths were due to heart- 
related causes (67%), as seen in this study. 
Although we did not observe differences between 
the crude and adjusted perioperative r lative risk for 
carotid artery versus aortic procedures, the late 
adjusted surgical RR remained somewhat elevated, 
although it was not statistically significant. This may 
be due to the fact that carotid atherosclerosis it elf 
seems to be an independent predictor for late 
events, 18'19 because the surgical effects would be 
expected to be more pronounced uring the periop- 
erative interval. The association between carotid 
atherosclerosis and late MI may also account for the 
diminished survival seen for patients undergoing 
carotid artery surgery during the first 2 years of 
follow-up. Our late results were similar to those of 
Cohen et al.,2° who reported a4-year mortality rate 
of 35% for 211 carotid endarterectomies. A  seen 
here, most of the late deaths were due to heart-related 
causes. 
It is important to emphasize that our study was 
restricted to successive patients undergoing vascular 
surgery who underwent dipyridamole thallium test- 
ing and prompt vascular surgery. The study is thus 
limited to those patients for whom the cardiac risk 
factor status could be reliably determined with both 
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clinical and dipyridamole thallium information, 21 
which minimizes misclassification bias. Furthermore, 
it is apparent that the indication for dipyridamole 
thallium testing was based on a clinical impression of 
elevated cardiac risk rather than the type of surgery 
required because only a fraction of all patients were 
tested regardless of procedure. For example, if all 
patients undergoing aortic surgery had been tested 
compared with a proportion of patients undergoing 
infrainguinal procedures, selection bias would be 
operative. However, this was not the case. Although 
our results may not be generalizable to all patients 
undergoing vascular surgery, it may be argued that 
cardiac risk would be inconsequential mong the 
greater population of patients undergoing vascular 
surgery. 2 
We have demonstrated that all dipyridamole 
thallium results, including fixed and reversible 
myocardial defects, ischemic electrocardiographic 
changes during testing, and one clinical marker, (i.e., 
a history of angina) independently identify patients 
who will have development of a perioperative MI. 
The fndings that fixed defects are also independently 
predictive of perioperative vents is unique to this 
study and may be attributable to the larger size of our 
cohort. We have further demonstrated that a similar 
spectrum of readily identifiable CAD markers such as 
diabetes, angina, congestive heart failure, and fixed 
dipyridamole thallium defects identify patients who 
are nearly two to four times more likely to experience 
a late MI compared with those who do not. In 
particular, patients who survived a perioperative MI 
had nearly a sixfold increase in the rate of subsequent 
cardiac events that were predominantly fatal. This 
finding has important implications for the assessment 
of cardiac risk beyond the operative period (i.e., after 
recovery from vascular surgery) and may warrant 
long-term follow-up and subsequent reatment of 
underlying CAD for patients who survive a periop- 
erative MI. 
In conclusion, the incidence of heart-related 
complications among patients undergoing vascular 
surgery with concurrent CAD or diabetes remains 
high and is primarily due to these readily identifiable 
factors rather than the nature of the surgical inter- 
vention that is required. This implies that a careful 
assessment of the patient's preoperative clinical status 
is vital to the determination of cardiac risk regardless 
of the type of surgical procedure indicated. The 
presence of significant risk factors may influence 
anesthetic management, perioperative monitoring, 
and the need for antiischemic therapy. Last, long- 
term follow up of patients who exhibit significant 
CAD markers, as well as those who survive a 
perioperative MI, is warranted because these indi- 
viduals are at substantially elevated risk for late 
cardiac events. 
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DISCUSSION 
Dr. Mart_ha McDaniel (White River Junction, Vt.). 
Operative risk prediction is a difficult and important task. 
Contributions to our knowledge of the topic are volu- 
minous. 
With sound methods in two institutions and a large 
group of patients, you have given us three important 
messages that are worth repeating. The first thing we heard 
is that, all other things (cardiac risk factors) being equal, the 
risk of having an MI is about he same in association with 
infrainguinal bypass as with aortic surgery. Do not let the 
anesthesiologists or anyone lse underestimate the risks of 
those "subcutaneous" operations characterized by ICD-9 
code 39.29. The second thing we heard is that the chance 
that an MI sustained at the time of a vascular reconstruction 
will be fatal is about one in three. This is a much more stable 
estimate than we have been able to obtain hitherto. The 
third thing worth noting is the importance of attention to 
the big picture. Having addressed a patient's immediate 
vascular problem, we must not forget that the long-term 
cardiac risk is substantial in this population. The next step 
is to consider whether attention to the coronary anatomy 
would improve the patient's quality or quantity of life. 
In the world of shared medical decision-making, our 
job is to help patients arrive at an accurate answer to their 
very important question: "What are my chances?" Your 
model incorporates the results of an expensive and 
time-consuming test, dipyridamole thallium scanning 
(DTHAL), to try to predict operative and long-term risk. 
In the past, one of your coauthors (Kim Eagle) has pointed 
out that diabetes i an independent risk factor for predicting 
operative morbidity. 21 Would you please tell us what we 
would lose in predictive value from your model if we 
incorporated only in expensive or free information, such as 
angina by history, the presence of diabetes, or electrocar- 
diographic hanges? 
Mr. Gilbert J. L'Italien. The issue of risk stratification 
has also occupied our interest for some time. Using the 
same patients as in this study, we developed a predictive 
model for perioperative outcomes with logistic regres- 
sion-weighted scores for the type and number of clinical 
markers; these were history of angina, MI, diabetes, 
congestive heart failure, and advanced age. Applying this 
model, we found,it possible to discriminate between low- 
and high-risk categories of patients. The observed event 
rate among 215 patients estimated to be at low risk was 2%, 
and for 35 patients at high risk it was 29%. We found that 
DTHAL added very tittle to the predictive value of the 
model in these patients at low and high risk. The patients 
at low risk could thus proceed irectly to surgery, and the 
high-risk subset might require more conservative manage- 
ment or perioperative monitoring. Thus we could make 
these decisions based on clinical markers alone, without he 
need for DTHAL, in nearly half of the study group. This 
would save considerable expense. One would also improve 
the predictive value of DTHAL by restricting the test to the 
300 or so patients at moderate risk. I want to emphasize 
that a weighted scoring system is preferable to merely 
counting the number or types of markers. 
Dr. John Herrmann (Worcester, Mass.). Do you 
separate your aortic aneurysm cases from your patients with 
ocdusive disease? My bias is that the patients with occlusive 
disease would probably have about he same risk factors as 
the patients undergoing infrainguinal and carotid artery 
procedures. 
Mr. L'Italien. We found no difference in the preva- 
lence of abnormal DTHAL results, that is, fixed or 
reversible defects, among patients with aortic disease whose 
indication for surgery was aneurysm compared with those 
undergoing operation for occlusive disease. Based on that 
result, we did not believe it was necessary to consider these 
two surgical groups eparately. However, this result may be 
due to some selection bias: some of the patients with 
occlusive disease may have been screened out. This is a 
possibility in a retrospective study. However, I do not 
believe there would be enough bias to account for all of the 
observed ifferences in the prevalence of risk factors or in 
the event rate between patients undergoing infrainguinal 
and aortic procedures. 
